BioSpace News Archive

Biomerica, Inc. announced that the Dubai government has officially approved insurance reimbursement for the EZ Detect colorectal disease at-home screening test, which is designed to detect an early warning sign of colorectal cancer and other colorectal diseases.

TeselaGen and the Joint BioEnergy Institute (JBEI) have signed a new 5-year contract to add expanded workflow capabilities, extending their relationship through 2027.

Artivion, Inc. today announced that it will present at the upcoming Deutsche Bank 31st Annual Leveraged Finance Conference on Tuesday, October 3, 2023.

Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI) and bYoRNA SAS (“bYoRNA”) today announced that they entered into a development and commercialization agreement to work on disruptive bioproduction technologies that will help exploit the therapeutic potential of messenger RNA (“mRNA”).

Veru Inc. (NASDAQ: VERU) today announced that in a September 21, 2023 meeting, the Company and FDA reached agreement on the design of a new Phase 3 clinical trial study to evaluate sabizabulin plus standard of care treatment in an expanded patient population, hospitalized adult patients who have broadly any type of virus causing ARDS.

IMUNON, Inc. announced the release of an enterprise video that highlights the company’s mission, vision, values, breakthroughs and technologies.

CorMedix Inc. (Nasdaq: CRMD) today announced that management will be giving a company presentation at the Cantor Fitzgerald Global Healthcare Conference being held in New York City on September 26 – 28, 2023.

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions, today announces positive safety, tolerability and efficacy data from its Phase Ib study exploring the interaction between selective serotonin reuptake inhibitors (“SSRIs”) and SPL026, native N, N-dimethyltryptamine (“DMT”), in patients with Major Depressive Disorder (“MDD”).

ISO 13485 certified Surface Solutions Group, LLC (SSG), a leading provider of coating technologies for the medical device industry, today announced that it will be showcasing its GlideMed™ sustainable, compliant coating and its 12 other coating solutions in Booth #3226 at the Medical Design & Manufacturing Conference & Expo (MD&M) in Minneapolis on October 10-11, 2023.

Silence Therapeutics plc today announced the Company will participate in a fireside chat at Chardan’s 7th Annual Genetic Medicines Conference on Tuesday,